α2A-肾上腺素受体的同源模建及与Yohimbine的对接研究  

Homology Modeling and Docking Studies of the α2A-adrenergic Receptor

作　　者：赵立峰[1] 丁晓琴[1] 丁俊杰[1] 陈冀胜[1] 

机构地区：[1]北京药物化学研究所,北京102205

出　　处：《物理化学学报》2005年第2期151-155,共5页Acta Physico-Chimica Sinica

摘　　要：通过对比多个与α2A-肾上腺素受体同属G-蛋白偶联受体的视紫红质蛋白序列,选择以相似性最大的牛视紫红质蛋白为模板,同源模建了α2A-肾上腺素受体的跨膜结构,并在结构中找到了体积为0.090nm3,已被报导的活性残基包围的活性位点.运用分子力学与动力学方法研究了此结构突变前后与抑制剂Yohimbine的对接情况,得到了与文献报道相吻合的结果.同时对接研究结果发现,在α2A-肾上腺素受体的结合位点周围的一个由色氨酸和两个苯丙氨酸组成的局部疏水区对抑制剂有稳定作用,并且天冬氨酸113作为氢键受体也对稳定抑制剂有重要作用.The properties of several rhodopsin sequences were analyzed by compar ing with -adrenergic receptor,and a great similarity was found between bovi ne rhodopsin and -adrenergic receptor.Therefore transmembrane helices of -adrenergic receptor were constructed homologically based on the bovine rhodo psin.In the newly constructed structure,a 0.090 nm3 active-site,which was enclo sed by several reported active residues,was found.In succession,docking research es of this structure as well as point-mutated ones with inhibitor Yohimbine wer e conducted using molecular dynamics.The results agree well to the experimental results reported.Furthermore the docking results indicate that a small hydrophob ic zone constructed by a tryptophan and two phenylalanines was critical in stabi lizing the inhibitor in the active site.At the same time,aspartic acid 113 also weighs heavily to stabilize the inhibitor as a H-bond acceptor.

关 键 词：跨膜蛋白 α2A-肾上腺素受体 同源模建 对接 YOHIMBINE 

分 类 号：R91[医药卫生—药学]